Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? a retrospective cohort study.
Wu-Tong JuYiyi ZhangYing LiuJing-Jing SunJiang LiMinjun DongQi SunWentao ShiTongchao ZhaoZhihang ZhouYingying HuangXinyu ZhouDongwang ZhuShengjin DouZhiyuan ZhangYue HeChenping ZhangRonghui XiaGuo-Pei ZhuLaiping ZhongPublished in: International journal of surgery (London, England) (2023)
These findings support further prospective evaluation of adjuvant radiotherapy omission, and suggest that de-escalation trials are warranted for LAROSCC surgery patients who received neoadjuvant therapy.
Keyphrases
- locally advanced
- early stage
- rectal cancer
- minimally invasive
- coronary artery bypass
- radiation therapy
- lymph node
- squamous cell carcinoma
- radiation induced
- surgical site infection
- papillary thyroid
- randomized controlled trial
- open label
- mesenchymal stem cells
- bone marrow
- clinical trial
- smoking cessation
- replacement therapy